[go: up one dir, main page]

ES2037278T3 - Tratamiento de la esterilidad. - Google Patents

Tratamiento de la esterilidad.

Info

Publication number
ES2037278T3
ES2037278T3 ES88830314T ES88830314T ES2037278T3 ES 2037278 T3 ES2037278 T3 ES 2037278T3 ES 88830314 T ES88830314 T ES 88830314T ES 88830314 T ES88830314 T ES 88830314T ES 2037278 T3 ES2037278 T3 ES 2037278T3
Authority
ES
Spain
Prior art keywords
release factor
treatment
somatropin
preparations containing
sterility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88830314T
Other languages
English (en)
Inventor
Andrea Fabbri
Costanzo Moretti
Laura Forni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SpA
Original Assignee
Industria Farmaceutica Serono SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT48222/87A external-priority patent/IT1224223B/it
Priority claimed from IT8847887A external-priority patent/IT1219554B/it
Application filed by Industria Farmaceutica Serono SpA filed Critical Industria Farmaceutica Serono SpA
Application granted granted Critical
Publication of ES2037278T3 publication Critical patent/ES2037278T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESRIBE EL USO DEL FACTOR DE LIBERACION DE SOMATROPINA (GRF) PARA EL TRATAMIENTO DE LA ESTERILIDAD. TAMBIEN SE DESCRIBE PARA TAL TRATAMIENTO EL USO DEL FACTOR DE LIBERACION DE SOMATROPINA JUNTO CON GONADOTROPINAS, EN ESPECIAL LA HORMONA ESTIMULADORA DEL FOLPICULO (FSH) O PREPARACIONES QUE CONTIENEN FSH. TAMBIEN SE DESCRIBEN LAS PREPARACIONES FARMACEUTICAS QUE CONTIENEN FACTOR DE LIBERACION DE SOMATROPINA, INCLUYENDO PREPARACIONES QUE CONTIENEN FACTOR DE LIBERACION DE SOMATROPINA Y HORMONA ESTIMULANTE DEL FOLICULO.
ES88830314T 1987-07-24 1988-07-22 Tratamiento de la esterilidad. Expired - Lifetime ES2037278T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT48222/87A IT1224223B (it) 1987-07-24 1987-07-24 Uso di un medicamento a base di un fattore di rilascio della somatotropina da solo o in combinazione con l'ormone follicolo-stimolante nel trattamento della sterilita
IT8847887A IT1219554B (it) 1988-04-26 1988-04-26 Trattamento dell' infertilita'

Publications (1)

Publication Number Publication Date
ES2037278T3 true ES2037278T3 (es) 1995-04-01

Family

ID=26329240

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88830314T Expired - Lifetime ES2037278T3 (es) 1987-07-24 1988-07-22 Tratamiento de la esterilidad.

Country Status (8)

Country Link
US (1) US5017557A (es)
EP (1) EP0300982B1 (es)
JP (1) JPH0611711B2 (es)
DE (1) DE3871010D1 (es)
DK (1) DK172947B1 (es)
ES (1) ES2037278T3 (es)
GR (1) GR3004596T3 (es)
IL (1) IL87168A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538948A (en) * 1987-01-30 1996-07-23 Novo Nordisk A/S Method for treating infertility comprising administering GnRH analog, gonadotrophins, and growth hormone
DK272789D0 (da) * 1989-06-02 1989-06-02 Novo Nordisk As Fremgangsmaade og praeparat til behandling af infertilitet
DK372589D0 (da) * 1989-07-28 1989-07-28 Novo Nordisk As Protein
SE9301667D0 (sv) * 1993-05-14 1993-05-14 Kabi Pharmacia Ab New use
US6159934A (en) * 1995-12-20 2000-12-12 Indiana University Foundation Use of GHRH-RP to stimulate stem cell factor production
EP1064934A1 (en) * 1999-06-30 2001-01-03 Applied Research Systems ARS Holding N.V. GRF-containing lyophilized pharmaceutical composition
AU6469401A (en) * 2000-05-19 2001-11-26 Serono Reproductive Biology In Pharmaceutically active compounds and methods of use
CA2499732A1 (en) * 2002-09-20 2004-04-15 Applied Research Systems Ars Holding N.V. Piperazine derivatives and methods of use
HRP20070271T3 (en) * 2003-07-25 2007-07-31 Laboratoires Serono S.A. Use of follicle stimulating hormone for reduction of spermatozoa chromosomal aberration in males
RU2010114051A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение grf-1(1-29) и кортиколиберина в качестве терапевтических средств

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1191611B (it) * 1985-05-15 1988-03-23 Eugenio E Muller Formalazioni farmaceutiche per stimolare la liberazione di ormone somatotropo

Also Published As

Publication number Publication date
IL87168A0 (en) 1988-12-30
DE3871010D1 (de) 1992-06-17
JPH01110630A (ja) 1989-04-27
IL87168A (en) 1993-07-08
US5017557A (en) 1991-05-21
EP0300982B1 (en) 1992-05-13
JPH0611711B2 (ja) 1994-02-16
EP0300982A3 (en) 1990-01-10
DK415288D0 (da) 1988-07-22
DK415288A (da) 1989-01-25
DK172947B1 (da) 1999-10-11
EP0300982A2 (en) 1989-01-25
GR3004596T3 (es) 1993-04-28

Similar Documents

Publication Publication Date Title
EG18379A (en) Novel pharmacological compounds
DE10199020I1 (de) Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit
MX9203026A (es) Enantiomero dextrogiro del alfa-(tetrahidro-4,5,5-tieno (3,2-c) piridil-5) (cloro-2 fenil)-acetato de metilo y composiciones farmaceuticas que lo contienen.
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
ES2098029T3 (es) Vacunas de hepatitis que contienen monofosforil lipido a 3-o-desacilado.
ES2091906T3 (es) Composiciones que comprenden derivados de un peptido de omega-conotoxina y su uso en el tratamiento del daño neuronal relacionado con la isquemia.
ES2060399T3 (es) Cristales de la hormona del crecimiento y procedimiento para la produccion de estos cristales de la hormona del crecimiento.
GB2100601B (en) An aromatase-inhibitor for use in a method of prophylaxis and/or of treatment by therapy of prostatic hyperplasia, and pharmaceutical preparations suitable for such a use.
ES2037278T3 (es) Tratamiento de la esterilidad.
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
DK430989A (da) Transdermalt anvendeligt laegemiddel med et indhold af farmaceutisk anvendelige glykosider
ES2018667B3 (es) Derivados del acido 4-qionolon-3-carboxilico, procedimiento para su obtencion y preparados farmaceuticos que los contienen.
DK158542C (da) Middel til behandling af infertilitet hos hoejere pattedyr eller mennesker
ES2085199B1 (es) Un procedimiento para la preparacion de una formulacion depot.
ES2059986T3 (es) Una composicion para el tratamiento de la insuficiencia exocrina del pancreas, y el uso de dicha composicion.
FI874450A7 (fi) Farmaseuttiset valmisteet alkuperältään toiminnallisten ja elimelliste n aivohäiriöiden hoitamiseen.
ES2069030T3 (es) Metodo para tratar funcionamiento defectuoso del corazon.
DE3883044D1 (de) Wirkstoff zur tumorbekaempfung.
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
GR3029886T3 (en) Method of preparing a radioactive rhenium complex solution.
ES2103811T3 (es) Terapia antiviral.
ES2063056T3 (es) Esteres poliaromaticos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
GR3018837T3 (en) Subcutaneous administration of human chorionic gonadotrophin.
DE3866747D1 (de) Jod enthaltende pharmazeutische zubereitung.
DK162477C (da) Anvendelse af gonadoliberin eller den gonadoliberin-analoge buserelin til fremstilling af et farmaceutisk praeparat til behandling af klimakterielle besvaerligheder og patologiske tilstande med forhoejet parathormonspejl

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 300982

Country of ref document: ES